Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,583,402
-$846,986 QoQ
Shares Held
547,599
-9.1% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 323 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. ADMA ranks #48 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in ADMA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,583,402 | 547,599 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,430,388 | 602,707 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $12,099,721 | 663,362 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $10,176,150 | 694,144 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $12,994,218 | 713,576 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $13,409,399 | 675,877 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $14,351,976 | 836,850 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $13,450,011 | 672,837 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $2,619,585 | 234,310 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $1,474,479 | 223,406 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $819,841 | 181,381 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $631,887 | 176,505 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $596,462 | 161,643 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $255,127 | 77,078 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $268,476 | 69,195 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $47,319 | 19,473 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $53,044 | 26,790 | Shares | Defined | 2022-08-22 | |
| 2021-03-31 | $12,430 | 7,063 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $13,772 | 7,063 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $16,880 | 7,063 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $30,647 | 10,460 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $30,124 | 10,460 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||